Lifeforce Med

Lifeforce Med serves executives and high-performing adults who want longitudinal, physician-directed optimization. The practice accepts both men and women. Ideal members commit to regular measurement, protocol adherence, and structured oversight over time. A private strategic consultation confirms mutual fit before enrollment begins.

The Comprehensive Assessment starts at $4,995 as a one-time fee. Executive Membership starts at $1,195 per month. Engagement runs on an annual basis to preserve continuity and measurable oversight. Enrollment is capacity-limited.

Lifeforce Med operates as a private, fee-for-service practice. Insurance does not cover membership fees. Depending on your plan and where services are obtained, insurance may cover certain laboratory or pharmacy items. The practice reviews specifics during enrollment.

The Comprehensive Assessment covers diagnostic laboratory intake, hormonal profiling, DEXA body composition and bone density analysis, genetic testing, cognitive evaluation, and VO2 max testing. An in-home blood draw is available where applicable. Dr. Rosenbloom uses the results to build a written, individualized Strategic Medical Blueprint.

Lifeforce Med conducts quarterly reassessment and biomarker recalibration. Lab frequency also depends on clinical context, active interventions, and how biomarkers trend over time. Adjustments happen when indicated, not just once per year.

Yes. Lifeforce Med offers telemedicine visits. Members can also access an in-home blood draw where available, so logistics do not interrupt the continuity of care.

Yes. Lifeforce Med focuses on performance, prevention, and physiologic optimization. Dr. Rosenbloom encourages members to maintain a separate primary care physician for acute needs and routine primary-care services. The two relationships work in parallel.

com to request enrollment forms. A private strategic consultation with Dr. Rosenbloom precedes enrollment to confirm mutual fit. Enrollment is capacity-limited, so the practice recommends initiating the conversation early.

When clinically appropriate and aligned with metabolic goals, Dr. Rosenbloom considers GLP-1 therapies as part of a broader strategy. That strategy also incorporates nutrition, training, sleep, and other relevant risk factors. He does not prescribe GLP-1 medications in isolation.

Lifeforce Med goes well beyond standard cholesterol panels. Dr. Rosenbloom uses advanced lipid analytics, inflammatory markers, vascular stiffness indicators, VO2 max measurement, and longitudinal cardiovascular reassessment. The goal is preserving arterial health and aerobic capacity across decades, not managing a single annual result.